A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
Active, not recruiting · NCT04671693 · Registry updated 2025-09-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | Ewing sarcoma, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, acute myeloid leukemia, connective tissue neoplasm, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm, non-Hodgkin lymphoma, osteosarcoma, sarcoma | Active, not recruiting | Not applicable | 2025-09-05 | NCT04671693 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biogaran | 1 |
| Centre Leon Berard | 67 |
| Fondation Apicil | 5 |
| Fédération Leucémie Espoir | 2 |
| Le défi Anthony | 1 |
| Malakoff-Humanis | 1 |
| Novartis | 114 |
| Roche Pharma AG | 59 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Leon Berard | Lyon | France | 70 |